OFFICIAL PUBLICATION OF

by its subsidiary APPco

Call to halt hydroxychloroquine prescribing, dispensing for COVID-19

Sheshtyn Paola 23/03/2020

PSA strongly advises pharmacists to refuse dispensing of hydroxychloroquine outside of approved indications, and urges prescribers to stop writing prescriptions as a ‘just in case’ measure Following President Trump’s announcement last week that hydroxychloroquine will be fast-tracked by the US Food and Drug Administration as a treatment for COVID-19 infection after showing “very encouraging early

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

‘Consumer confusion, pharmacist frustration’ if current system continues

The first and foremost role of "expanded scope" is the HMR and collaborative medication management. A clear no brainer which…

Big Pharma

‘I can feel the walls closing in on me as this snowballs’

I'm yet to encounter a corporate provider, Debbie, with the benefits you describe around quality improvement with the corporate business…

Kelly Abbott

‘I can feel the walls closing in on me as this snowballs’

I would argue quality varies in any profession. Most GPs will not refer to a provider where the quality is…

Big Pharma

Wesfarmers targets affordable healthcare

When healthcare is treated as a commodity and patients regarded as consumers, health outcomes are compromised and overall healthcare spending…

Edward Hatfield

Call to halt hydroxychloroquine prescribing, dispensing for COVID-19

Previous ‘Women who come into your pharmacy may not have anywhere to go.’

Next Leading tech company highlights surge in meds orders

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous ‘Women who come into your pharmacy may not have anywhere to go.’

Next Leading tech company highlights surge in meds orders

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.